PRESS RELEASE For immediate release Devonian Health Group announces the publication of results of in vitro assessment of the antioxidant and UV protection properties of thylakoid extracts in Journal of Cosmetic Dermatology. QUEBEC, April 8, 2019 – Devonian...
Press Releases
Devonian Healthcare Group Reports Key Financial Results for Quarter Ended January 31, 2019
PRESS RELEASE For immediate release Devonian Healthcare Group Reports Key Financial Results for Quarter Ended January 31, 2019 Quebec, Quebec – April 2, 2019 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical...
Devonian Health Group issues Securities In Interest Settlement Due To Debenture Holders and grants options
PRESS RELEASE For immediate release Devonian Health Group issues Securities In Interest Settlement Due To Debenture Holders and grants options NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. QUEBEC, March 29, 2019 – Devonian...
Devonian Announces voting results of the Annual General and Special Meeting
PRESS RELEASE For immediate release Devonian Announces voting results of the Annual General and Special Meeting QUÉBEC, Québec – January 31st, 2019 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical...
Devonian Health Group Provides an update on its Phase 2 Clinical Study in Atopic Dermatitis and Announces plans for the first photoprotection product issued from its Cosmeceutical R&D program
PRESS RELEASE For immediate release Devonian Health Group Provides an update on its Phase 2 Clinical Study in Atopic Dermatitis and Announces plans for the first photoprotection product issued from its Cosmeceutical R&D program QUEBEC, January 29, 2019 –...
Devonian Health Group Announces the refinancing of the loan on its pharmaceutical facility
PRESS RELEASE For immediate release Devonian Health Group Announces the refinancing of the loan on its pharmaceutical facility New favourable terms provide liquidity of more than $600,000 annually to be applied to corporate growth strategy QUEBEC, January 23rd,...
Devonian Health Group Announces 2018 Annual General Shareholder’s Meeting
PRESS RELEASE For immediate release Devonian Health Group Announces 2018 Annual General Shareholder’s Meeting QUEBEC - December 20, 2018 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage biopharmaceutical corporation...
Devonian Health Group announces the recognition of Sybil Dahan, President of Altius Healthcare, as inductee into the 2018 Canadian Healthcare Marketing Hall of Fame.
PRESS RELEASE For immediate release Devonian Health Group announces the recognition of Sybil Dahan, President of Altius Healthcare, as inductee into the 2018 Canadian Healthcare Marketing Hall of Fame. Quebec, Quebec – November 12, 2018 – Devonian Health Group...
Devonian Health Group Receives 2018 Best Anti-Aging Skin Treatment Technology from LUX Life Magazine.
PRESS RELEASE For immediate release Devonian Health Group Receives 2018 Best Anti-Aging Skin Treatment Technology from LUX Life Magazine. QUEBEC, October 3rd, 2018 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage...
Devonian Health Group announces the completion of the second tranche of its previously announced private placement and provides an update.
PRESS RELEASE For immediate release Devonian Health Group announces the completion of the second tranche of its previously announced private placement and provides an update. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED...